Pharmaceutical Business review

Takeda to open new development center in China

Takeda Pharmaceutical (China) Company in Taizhou is responsible for marketing and sales, and Tianjin Takeda Pharmaceuticals in Tianjin is responsible for manufacturing.

Together with Takeda China and Tianjin Takeda, TSDC will work on enhancing the company’s clinical development activities within the Asian region, with a focus on China for general medicine.

The establishment of TSDC will provide a powerful addition to this global development infrastructure, the company said.

Through TSDC, Takeda will continue to conduct high quality clinical trials towards regulatory approval in Asia, with a growing emphasis on China.